from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3273/-

LFCtreatmentdescriptionclass of inhibitor

0.597

Amikacinug/mL Amikacintranslation

-0.108

Cap5-10ug/mL Capreomycintranslation

-0.083

Rox10-50 ug/mL Roxithromycintranslation

-0.622

SM2-5 ug/mL Streptomycintranslation

-1.909

Tet5-10 ug/mL Tetracyclinetranslation

0.035

Rif0.2-5ug/mL Rifampicintranscription

-0.179

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.770

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.085

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.437

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.839

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.285

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.452

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.672

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.986

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.237

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.373

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.748

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.590

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.739

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.151

KCN5-20 ug/mL Potassium cyaniderespiration

0.310

NaN30.2-2 mM Sodium aziderespiration

0.021

Nigericin50 uM Nigericinrespiration

-0.237

TRC10-150 ug/mL Triclosanrespiration

-1.616

TRZ10-25 ug/mL Thioridazinerespiration

-2.732

Valinomycin0.5-10 uM Valinomycinrespiration

-0.505

ZnSO42 mM ZnSO4respiration

-0.161

menadione6-10 ug/mL Menadionerespiration

0.046

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.434

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.265

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.100

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.334

NRP_1Non-replicating persistence stage 1dosRassociated

0.407

Amp0.2mg/mL AmpicillincellWall

0.184

Cephalexin20-100 ug/mL CephalexincellWall

0.470

Cerulenin0.32-5 ug/mL CerulenincellWall

0.480

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.239

EMB10-20 ug/mL EthambutolcellWall

0.340

Eta12-40 ug/mL EthionamidecellWall

0.392

INH0.2-0.4 ug/mL IsoniazidcellWall

0.642

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.355

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.276

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.127

BZA0.12 mg/mL BenzamidearomaticAmides

0.389

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.628

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.011

H2O24 mM hydrogen peroxideDNAdamaging

0.599

Levo10 ug/mL LevofloxacinDNAdamaging

0.385

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.298

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.751

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.919

UVUV-irradiationDNAdamaging

-0.926

ARP41-4 ug/mL Antitubercular compound ARP4?

1.061

Antimycin12.5-50 ug/mL Antimycin A?

0.387

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.705

PA_110-50 ug/mL Antitubercular compound PA-1?

0.493

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.994

PA8240.2-2 ug/mL PA-824?

-0.226

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.443

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.067

Verapamil50 uM Verapamil?

0.486

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.216

methoxatin10-20 ug/mL Methoxatin?